FORTIS.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 12:59):

Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India, the United Arab Emirates, Sri Lanka, and internationally...

Stats
Šios dienos apimtis	256 171
Vidutinė apimtis	1.40M
Rinkos kapitalizacija	334.86B
EPS	INR0 ( 2024-02-06 )
Kita pelno data	( INR1.940 ) 2024-05-21
Last Dividend	INR1.000 ( 2023-07-20 )
Next Dividend	INR0 ( N/A )
P/E	60.59
ATR14	INR0.435 (0.10%)

Tūris Koreliacija

Ilgas: -0.47 (neutral)

Trumpas: -0.52 (weak negative)

Signal:(48.093) Neutral

Fortis Healthcare Limited Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
NOVARTIND.NS	0.907
BAYERCROP.NS	0.901
PIONEEREMB.NS	0.901
BIOFILCHEM.NS	0.9
TNPETRO.NS	0.896
AJRINFRA.NS	0.896
FSC.NS	0.895
GANGAFORGE.NS	0.895
DIAMONDYD.NS	0.894
SUULD.NS	0.891

10 Labiausiai neigiamai susiję koreliacijos
TARMAT.NS	-0.888
HARIOMPIPE.NS	-0.864
CIGNITITEC.NS	-0.862
SOMATEX.NS	-0.861
KIRLFER.NS	-0.861
KAYNES.NS	-0.861
SIEMENS.NS	-0.858
ISMTLTD.NS	-0.856
SONATSOFTW.NS	-0.855
BSELINFRA.NS	-0.853

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Fortis Healthcare Limited Koreliacija - Valiuta/Žaliavos

-0.22
( neutral )

-0.27
( neutral )

0.00
( neutral )

-0.09
( neutral )

-0.38
( neutral )

-0.29
( neutral )

Fortis Healthcare Limited Finansinės ataskaitos

Annual	2022
Pajamos:	INR62.98B
Bruto pelnas:	INR35.31B (56.08 %)
EPS:	INR7.80

FY	2022
Pajamos:	INR62.98B
Bruto pelnas:	INR35.31B (56.08 %)
EPS:	INR7.80

FY	2022
Pajamos:	INR56.39B
Bruto pelnas:	INR42.21B (74.85 %)
EPS:	INR10.46

FY	2021
Pajamos:	INR40.09B
Bruto pelnas:	INR21.65B (54.00 %)
EPS:	INR-1.450

Financial Reports:

No articles found.

Fortis Healthcare Limited Dividends

(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR1.000 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Fortis Healthcare Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.45 - low (14.69%) | Divividend Growth Potential Score: 4.00 - Decrease likely (20.09%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.000	2023-07-20
Last Dividend	INR1.000	2023-07-20
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR1.000	--
Avg. Dividend % Per Year	0.12%	--
Score	1.17	--
Div. Sustainability Score	3.45
Div.Growth Potential Score	4.00
Div. Directional Score	3.72	--

Next Divdend (Est)
(2024-04-28)

INR2.00 Estimate 2.50 %

Dividend Stability

0.20 Very Poor

Dividend Score

1.17

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2023	INR1.000	0.36%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TOUCHWOOD.NS	Dividend Junior	2023-09-22	Annually	6	0.15%
PGIL.NS	Dividend Junior	2023-09-01	Annually	17	1.08%
JINDALSAW.NS	Dividend Junior	2023-06-13	Annually	22	1.62%
DEEPAKNTR.NS	Dividend Junior	2023-07-27	Annually	14	0.25%
SKMEGGPROD.NS	Dividend Junior	2023-08-30	Sporadic	21	0.95%
MGEL.NS	Dividend Junior	2023-08-08	Annually	5	0.59%
HARSHA.NS	Dividend Junior	2023-09-20	Insufficient data to determine frequency	2	0.09%
BDL.NS	Dividend Junior	2023-09-20	Semi-Annually	7	1.17%
PTC.NS	Dividend Knight	2023-09-20	Annually	21	6.06%
KDDL.NS	Dividend Junior	2023-09-22	Annually	8	0.29%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0819	1.500	8.36	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0703	1.500	-0.330	-0.494	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	6.77	1.000	8.60	8.60	[3 - 30]
operatingCashFlowPerShareTTM	8.80	2.00	7.07	10.00	[0 - 30]
freeCashFlowPerShareTTM	8.80	2.00	5.60	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.553	1.000	4.12	4.12	[0.2 - 0.8]
operatingProfitMarginTTM	0.128	1.000	9.43	9.43	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.45

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	60.59	1.000	3.98	0	[1 - 100]
returnOnEquityTTM	0.0703	2.50	-0.212	-0.494	[0.1 - 1.5]
freeCashFlowPerShareTTM	8.80	2.00	7.07	10.00	[0 - 30]
dividendYielPercentageTTM	0.225	1.500	4.36	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.80	2.00	7.07	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	9.90	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0984	1.000	-0.0403	0	[0.1 - 0.5]
Total Score				4.00

Fortis Healthcare Limited

Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India, the United Arab Emirates, Sri Lanka, and internationally. Its healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. The company offers services in the areas of cardiac science, cosmetology, dental science, dermatology, diabetes/endocrinology, emergency medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, haematology, infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, rheumatology, thoracic surgery, transplantation medicine, urology, and other support specialties. As of March 31, 2022, it operated a network of 26 hospitals with approximately 4,300 operational beds. The company also operates approximately 426 diagnostics centers and laboratories; and 2,550 collection centers. The company was incorporated in 1996 and is based in Gurugram, India.